These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 25769314)
21. Effect of a phytopharmaceutical medicine, Ginko biloba extract 761, in an animal model of Parkinson's disease: therapeutic perspectives. Rojas P; Montes P; Rojas C; Serrano-García N; Rojas-Castañeda JC Nutrition; 2012; 28(11-12):1081-8. PubMed ID: 22817828 [TBL] [Abstract][Full Text] [Related]
22. Aquaporin-4 deficiency diminishes the differential degeneration of midbrain dopaminergic neurons in experimental Parkinson's disease. Zhang J; Yang B; Sun H; Zhou Y; Liu M; Ding J; Fang F; Fan Y; Hu G Neurosci Lett; 2016 Feb; 614():7-15. PubMed ID: 26748031 [TBL] [Abstract][Full Text] [Related]
23. PEP-1-ribosomal protein S3 protects dopaminergic neurons in an MPTP-induced Parkinson's disease mouse model. Ahn EH; Kim DW; Shin MJ; Kim YN; Kim HR; Woo SJ; Kim SM; Kim DS; Kim J; Park J; Eum WS; Hwang HS; Choi SY Free Radic Biol Med; 2013 Feb; 55():36-45. PubMed ID: 23178948 [TBL] [Abstract][Full Text] [Related]
25. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease. Zuo L; Motherwell MS Gene; 2013 Dec; 532(1):18-23. PubMed ID: 23954870 [TBL] [Abstract][Full Text] [Related]
26. Stimulation of electron transport as potential novel therapy in Parkinson's disease with mitochondrial dysfunction. Vos M; Verstreken P; Klein C Biochem Soc Trans; 2015 Apr; 43(2):275-9. PubMed ID: 25849929 [TBL] [Abstract][Full Text] [Related]
27. Neuroprotective strategies to prevent and treat Parkinson's disease based on its pathophysiological mechanism. Lee Y; Kim MS; Lee J Arch Pharm Res; 2017 Oct; 40(10):1117-1128. PubMed ID: 28952032 [TBL] [Abstract][Full Text] [Related]
28. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease. Novikova L; Garris BL; Garris DR; Lau YS Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572 [TBL] [Abstract][Full Text] [Related]
29. Novel role of aquaporin-4 in CD4+ CD25+ T regulatory cell development and severity of Parkinson's disease. Chi Y; Fan Y; He L; Liu W; Wen X; Zhou S; Wang X; Zhang C; Kong H; Sonoda L; Tripathi P; Li CJ; Yu MS; Su C; Hu G Aging Cell; 2011 Jun; 10(3):368-82. PubMed ID: 21255222 [TBL] [Abstract][Full Text] [Related]
30. Pten ablation in adult dopaminergic neurons is neuroprotective in Parkinson's disease models. Domanskyi A; Geissler C; Vinnikov IA; Alter H; Schober A; Vogt MA; Gass P; Parlato R; Schütz G FASEB J; 2011 Sep; 25(9):2898-910. PubMed ID: 21593433 [TBL] [Abstract][Full Text] [Related]
31. Meloxicam ameliorates motor dysfunction and dopaminergic neurodegeneration by maintaining Akt-signaling in a mouse Parkinson's disease model. Tasaki Y; Yamamoto J; Omura T; Sakaguchi T; Kimura N; Ohtaki K; Ono T; Suno M; Asari M; Ohkubo T; Noda T; Awaya T; Shimizu K; Matsubara K Neurosci Lett; 2012 Jul; 521(1):15-9. PubMed ID: 22617635 [TBL] [Abstract][Full Text] [Related]
32. HMGB1 Mediates Inflammation-Induced DMT1 Increase and Dopaminergic Neurodegeneration in the Early Stage of Parkinsonism. Liang T; Yang SX; Qian C; Du LD; Qian ZM; Yung WH; Ke Y Mol Neurobiol; 2024 Apr; 61(4):2006-2020. PubMed ID: 37833459 [TBL] [Abstract][Full Text] [Related]
33. Minor retinal degeneration in Parkinson's disease. Huang YM; Yin ZQ Med Hypotheses; 2011 Feb; 76(2):194-6. PubMed ID: 20933338 [TBL] [Abstract][Full Text] [Related]
34. Microglia-Mediated Neuroinflammation and Neurotrophic Factor-Induced Protection in the MPTP Mouse Model of Parkinson's Disease-Lessons from Transgenic Mice. Machado V; Zöller T; Attaai A; Spittau B Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26821015 [TBL] [Abstract][Full Text] [Related]
35. Neuroinflammation in the pathophysiology of Parkinson's disease and therapeutic evidence of anti-inflammatory drugs. Bassani TB; Vital MA; Rauh LK Arq Neuropsiquiatr; 2015 Jul; 73(7):616-23. PubMed ID: 26200058 [TBL] [Abstract][Full Text] [Related]
36. Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model. Rai SN; Yadav SK; Singh D; Singh SP J Chem Neuroanat; 2016 Jan; 71():41-9. PubMed ID: 26686287 [TBL] [Abstract][Full Text] [Related]
37. Neuroprotective effects of piperine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease mouse model. Yang W; Chen YH; Liu H; Qu HD Int J Mol Med; 2015 Nov; 36(5):1369-76. PubMed ID: 26648012 [TBL] [Abstract][Full Text] [Related]
38. Intranasal PRGF-Endoret enhances neuronal survival and attenuates NF-κB-dependent inflammation process in a mouse model of Parkinson's disease. Anitua E; Pascual C; Pérez-Gonzalez R; Orive G; Carro E J Control Release; 2015 Apr; 203():170-80. PubMed ID: 25702964 [TBL] [Abstract][Full Text] [Related]
39. Synaptic dysfunction in Parkinson's disease. Picconi B; Piccoli G; Calabresi P Adv Exp Med Biol; 2012; 970():553-72. PubMed ID: 22351072 [TBL] [Abstract][Full Text] [Related]
40. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease. Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]